BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
31.19
+1.39 (4.66%)
At close: Jul 10, 2026
-44.20% (1Y)
| Market Cap | 13.57B -43.2% |
| Revenue (ttm) | 1.30B +9.1% |
| Net Income | 50.85M -63.2% |
| EPS | 0.12 -63.7% |
| Shares Out | 435.23M |
| PE Ratio | 262.24 |
| Forward PE | n/a |
| Dividend | 0.02 (0.05%) |
| Ex-Dividend Date | Jun 9, 2026 |
| Volume | 9,774,359 |
| Open | 29.56 |
| Previous Close | 29.80 |
| Day's Range | 29.25 - 31.98 |
| 52-Week Range | 29.00 - 122.59 |
| Beta | 0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 31, 2026 |